Request Deal Involvement

Venrock Healthcare Capital Partners led a $120m Series B round in Artiva Biotherapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Westwicke

pr advisors

Westwicke

Little Dog Communications

pr advisors

Little Dog Communications

or

Principals

ACUTA CAPITAL

bidder

ACUTA CAPITAL

5AM VENTURES LLC

bidder

5AM VENTURES LLC

VENROCK

bidder

VENROCK

ARTIVA BIOTHERAPEUTICS

target

ARTIVA BIOTHERAPEUTICS

VENBIO LLC

bidder

VENBIO LLC

WELLINGTON MANAGEMENT

bidder

WELLINGTON MANAGEMENT

ECOR1 CAPITAL

bidder

ECOR1 CAPITAL

JANUS HENDERSON INVESTORS

bidder

JANUS HENDERSON INVESTORS

FRANKLIN TEMPLETON INVESTMENTS CORPORATION

bidder

FRANKLIN TEMPLETON INVESTMENTS CORPORATION

SURVEYOR CAPITAL

bidder

SURVEYOR CAPITAL

CORMORANT ASSET MANAGEMENT

bidder

CORMORANT ASSET MANAGEMENT

LOGOS CAPITAL

bidder

LOGOS CAPITAL

RA CAPITAL MANAGEMENT

bidder

RA CAPITAL MANAGEMENT

RTW INVESTMENTS

bidder

RTW INVESTMENTS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Venrock Healthcare Capital Partners led a $120m Series B round in Artiva Biotherapeutics.